| 2020 |
Kitaguchi K, Kashii M, Ebin K, Kaito T, Okada R, Makino T, Etani Y, Ishimoto T, Nakano T, Yoshikawa H. The combined effects of teriparatide and anti-RANKL monoclonal antibody on bone defect regeneration in ovariectomized mice. Bone. January 2020;130:115077. |
1 |
0 |
| 2020 |
Etani Y, Ebina K, Hirao M, Kitaguchi K, Kashii M, Ishimoto T, Nakano T, Okamura G, Miyama A, Takami K, Goshima A, Kanamoto T, Nakata K, Yoshikawa H. Combined effect of teriparatide and an anti-RANKL monoclonal antibody on bone defect regeneration in mice with glucocorticoid-induced osteoporosis. Bone. October 2020;139:115525. |
0 |
0 |
| 2022 |
Kashii M, Kamatani T, Abe S, Yoshida A, Yamamoto K, Koizumi K, Mizuno N, Kuriyama K, Yoshikawa H. Tolerability of the first infusion of once-yearly zoledronic acid within one to two weeks after hip fracture surgery. Bone. February 2022;155:116298. |
0 |
0 |
| 2020 |
Kushioka J, Kaito T, Okada R, Ishiguro H, Bal Z, Kodama J, Chijimatsu R, Pye M, Narimatsu M, Wrana JL, Inoue Y, Ninomiya H, Yamamoto S, Saitou T, Yoshikawa H, Imamura T. A novel negative regulatory mechanism of Smurf2 in BMP/sSmad signaling in bone. Bone Res. 2020;8:41. |
0 |
0 |
| 2022 |
Akiyama K, Sakai T, Koyanagi J, Yoshikawa H, Sugamoto K. Age-related differences in morphology and kinematics of the native hip. J Orthop Res. February 2022;40(2):359-369. |
0 |
0 |
| 2020 |
Ohata Y, Takeyari S, Nakano Y, Kitaoka T, Nakayama H, Bizaoui V, Yamamoto K, Miyata K, Yamamoto K, Fujiwara M, Kubota T, Michigami T, Yamamoto K, Yamamoto T, Namba N, Ebina K, Yoshikawa H, Ozono K. Correction to: comprehensive genetic analyses using targeted next-generation sequencing and genotype-phenotype correlations in 53 japanese patients with osteogenesis imperfecta. Osteoporos Int. June 2020;31(6):1185-1185. |
0 |
0 |